<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>FDA approval on FinanClub</title>
    <link>https://finan.club/tags/fda-approval/</link>
    <description>Recent content in FDA approval on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 12 Aug 2023 05:17:13 +0000</lastBuildDate><atom:link href="https://finan.club/tags/fda-approval/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>JNJ</title>
      <link>https://finan.club/us/jnj/</link>
      <pubDate>Sat, 12 Aug 2023 05:17:13 +0000</pubDate>
      
      <guid>https://finan.club/us/jnj/</guid>
      <description>score:12
Chances: Impressive second-quarter earnings and revenue beat ratios in the healthcare sector highlight positive performance. Johnson &amp;amp; Johnson&amp;rsquo;s reputation as a dividend stock could attract investors looking for consistent income. FDA approval for antibody-based therapy Talvey indicates potential for innovation in difficult-to-treat blood cancer treatment.</description>
    </item>
    
  </channel>
</rss>
